Literature DB >> 23024188

Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.

George S Karagiannis1, Theofilos Poutahidis, Susan E Erdman, Richard Kirsch, Robert H Riddell, Eleftherios P Diamandis.   

Abstract

Neoplastic cells recruit fibroblasts through various growth factors and cytokines. These "cancer-associated fibroblasts" (CAF) actively interact with neoplastic cells and form a myofibroblastic microenvironment that promotes cancer growth and survival and supports malignancy. Several products of their paracrine signaling repertoire have been recognized as tumor growth and metastasis regulators. However, tumor-promoting cell signaling is not the only reason that makes CAFs key components of the "tumor microenvironment," as CAFs affect both the architecture and growth mechanics of the developing tumor. CAFs participate in the remodeling of peritumoral stroma, which is a prerequisite of neoplastic cell invasion, expansion, and metastasis. CAFs are not present peritumorally as individual cells but they act orchestrated to fully deploy a desmoplastic program, characterized by "syncytial" (or collective) configuration and altered cell adhesion properties. Such myofibroblastic cohorts are reminiscent of those encountered in wound-healing processes. The view of "cancer as a wound that does not heal" led to useful comparisons between wound healing and tumorigenesis and expanded our knowledge of the role of CAF cohorts in cancer. In this integrative model of cancer invasion and metastasis, we propose that the CAF-supported microenvironment has a dual tumor-promoting role. Not only does it provide essential signals for cancer cell dedifferentiation, proliferation, and survival but it also facilitates cancer cell local invasion and metastatic phenomena.

Entities:  

Mesh:

Year:  2012        PMID: 23024188      PMCID: PMC4399759          DOI: 10.1158/1541-7786.MCR-12-0307

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  138 in total

Review 1.  EMT: when epithelial cells decide to become mesenchymal-like cells.

Authors:  Raghu Kalluri
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

2.  Myofibroblast communication is controlled by intercellular mechanical coupling.

Authors:  Lysianne Follonier; Sébastien Schaub; Jean-Jacques Meister; Boris Hinz
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

3.  Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis.

Authors:  Boris Hinz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

4.  Expression of matrix metalloproteinases (MMP)-12 by myofibroblasts during alkali-burned corneal wound healing.

Authors:  Haruhi Iwanami; Masamichi Ishizaki; Yuh Fukuda; Hiroshi Takahashi
Journal:  Curr Eye Res       Date:  2009-03       Impact factor: 2.424

5.  A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells.

Authors:  Alok Tomar; Ssang-Taek Lim; Yangmi Lim; David D Schlaepfer
Journal:  J Cell Sci       Date:  2009-05-12       Impact factor: 5.285

Review 6.  Stromal myofibroblasts are drivers of invasive cancer growth.

Authors:  Olivier De Wever; Pieter Demetter; Marc Mareel; Marc Bracke
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

Review 7.  Mechanics, malignancy, and metastasis: the force journey of a tumor cell.

Authors:  Sanjay Kumar; Valerie M Weaver
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

8.  Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.

Authors:  Lukas J A C Hawinkels; Hein W Verspaget; Johan J van der Reijden; Johanna M van der Zon; Jan H Verheijen; Daniel W Hommes; Cornelis B H W Lamers; Cornelis F M Sier
Journal:  Cancer Sci       Date:  2009-04       Impact factor: 6.716

9.  Senescence of activated stellate cells limits liver fibrosis.

Authors:  Valery Krizhanovsky; Monica Yon; Ross A Dickins; Stephen Hearn; Janelle Simon; Cornelius Miething; Herman Yee; Lars Zender; Scott W Lowe
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

Review 10.  The role of endothelial-to-mesenchymal transition in cancer progression.

Authors:  S Potenta; E Zeisberg; R Kalluri
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more
  206 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

3.  Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.

Authors:  Tsuyoshi Konishi; Yoshifumi Shimada; Lik Hang Lee; Marcela S Cavalcanti; Meier Hsu; Jesse Joshua Smith; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Efsevia Vakiani; Mithat Gonen; Jinru Shia; Martin R Weiser
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

Review 4.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

5.  Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.

Authors:  George S Karagiannis; Aaron Berk; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2013-04-18       Impact factor: 6.603

6.  Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.

Authors:  Chiuan-Ren Yeh; Iawen Hsu; Wenbin Song; Hongchiang Chang; Hiroshi Miyamoto; Guang-Qian Xiao; Lei Li; Shuyuan Yeh
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

7.  A novel technique for in situ uniaxial tests of self-assembled soft biomaterials.

Authors:  Mohamed Elhebeary; Md Abul Bashar Emon; Onur Aydin; M Taher A Saif
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

Review 8.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

9.  EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.

Authors:  Xianglan Zhang; Im-Hee Jung; Young Sun Hwang
Journal:  Tumour Biol       Date:  2015-09-19

10.  Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.

Authors:  George S Karagiannis; Ann Treacy; David Messenger; Andrea Grin; Richard Kirsch; Robert H Riddell; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2014-04-19       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.